Albemarle (ALB) Suffers a Larger Drop Than the General Market: Key Insights
The most recent trading session ended with Albemarle (ALB) standing at $89.15, reflecting a -0.93% shift from the previouse trading day's closing. This change lagged the S&P 500's daily loss of 0.04%. Elsewhere, the Dow saw an upswing of 0.07%, while the tech-heavy Nasdaq depreciated by 0.05%.Prior to today's trading, shares of the specialty chemicals company had lost 16.66% over the past month. This has lagged the Basic Materials sector's loss of 8.95% and the S&P 500's gain of 1.05% in that time.Analysts and investors alike will be keeping a close eye on the performance of Albemarle in its upcoming earnings disclosure. The company's upcoming EPS is projected at -$0.36, signifying a 119.46% drop compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $1.4 billion, indicating a 40.44% decrease compared to the same quarter of the previous year.For the annual period, the Zacks Consensus Estimates anticipate earnings of -$1.49 per share and a revenue of $5.47 billion, signifying shifts of -106.7% and -43.16%, respectively, from the last year.Investors should also take note of any recent adjustments to analyst estimates for Albemarle. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. As of now, Albemarle holds a Zacks Rank of #3 (Hold).The Chemical - Diversified industry is part of the Basic Materials sector. Currently, this industry holds a Zacks Industry Rank of 206, positioning it in the bottom 18% of all 250+ industries.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.You can find more information on all of these metrics, and much more, on Zacks.com.Free: 5 Stocks to Buy As Infrastructure Spending SoarsTrillions of dollars in Federal funds have been earmarked to repair and upgrade America’s infrastructure. In addition to roads and bridges, this flood of cash will pour into AI data centers, renewable energy sources and more.In, you’ll discover 5 surprising stocks positioned to profit the most from the spending spree that’s just getting started in this space.Download How to Profit from the Trillion-Dollar Infrastructure Boom absolutely free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Albemarle Corporation (ALB): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Quelle: Zacks
Nachrichten zu Albemarle Corp.
Analysen zu Albemarle Corp.
Datum | Rating | Analyst | |
---|---|---|---|
16.11.2017 | Albemarle Hold | Deutsche Bank AG | |
10.11.2017 | Albemarle Outperform | RBC Capital Markets | |
09.11.2017 | Albemarle Neutral | UBS AG | |
27.10.2017 | Albemarle Outperform | BMO Capital Markets | |
25.09.2017 | Albemarle Neutral | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
10.11.2017 | Albemarle Outperform | RBC Capital Markets | |
27.10.2017 | Albemarle Outperform | BMO Capital Markets | |
08.05.2017 | Albemarle Outperform | RBC Capital Markets | |
17.03.2017 | Albemarle Outperform | RBC Capital Markets | |
01.03.2017 | Albemarle Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
16.11.2017 | Albemarle Hold | Deutsche Bank AG | |
09.11.2017 | Albemarle Neutral | UBS AG | |
25.09.2017 | Albemarle Neutral | Robert W. Baird & Co. Incorporated | |
10.03.2016 | Albemarle Neutral | Seaport Global Securities | |
03.02.2015 | Albemarle Market Perform | Cowen and Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
16.08.2011 | Albemarle underperform | Oppenheimer & Co. Inc. | |
04.01.2006 | Update Albemarle Corp.: Underweight | JP Morgan |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Albemarle Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen